Become A Featured Company

Medical Marijuana (MJNA) Soars Ahead of Pivotal U.S. Elections

Ryan Allway

November 2nd, 2016

News, Top News

The upcoming elections on November 8th could be a watershed moment for the cannabis industry. With five states voting to legalize recreational marijuana and four others voting to legalize medical marijuana, investors could see the legal market for cannabis and related technologies significantly expand next year. Advocates are also hoping that California’s decision could be the tipping point needed to force the federal government to alter its antiquated views regarding the medicinal aspects of cannabis.

In this article, we will take a look at a stock that has tripled over the past several months. This stock still represents one of the most compelling opportunities in its sector with potential upside for speculative-minded investors.

Leader in the Space

Medical Marijuana Inc. (OTC Pink: MJNA) is diversified conglomerate focused on the emerging cannabis industry. With a focus on the extraction and formulation of cannabinoid-based products, the company targets pharmaceutical, nutraceutical, and cosmeceutical industries. These products are distributed across a growing number of countries around the world, including Mexico, Brazil, Paraguay, and Puerto Rico.

The company owns a portfolio of eight companies focused on cannabinoid-based pharmaceuticals and medications using hemp as a source, including:

  • HempMeds® (100% owned) – A distribution company focused on bringing high quality CBD hemp oil products like its RSHO™ product line to global markets.
  • Axim Biotech (45.5% owned) – A biotech company focused on cannabinoid-based pharmaceuticals and supplements like Canchew® gum through clinical trials.
  • Kannalife (16.7% owned) – A biomedical company focused on the antioxidant and neuroprotective properties of cannabinoids with an exclusive right to the ‘507’ patent.
  • Kannaway (100% owned) – A direct marketing company focused on bringing cannabis products to consumers through brand ambassadors.
  • MPS International (50% owned) – The nation’s first security and armored transport service provider to the cannabis industry with clients across the country.
  • HempMeds Brasil (100% owned) – The first provider of legal medical cannabis products and the exclusive distributor of RSHO™ in Brazil.
  • HempMeds Mexico (100% owned) – The exclusive distributor of RSHO™ in Mexico and the first company to have a medical cannabis product approved for import.
  • Wellness Managed Services (100% owned) – A provider of comprehensive business services to cooperatives, collectives, dispensaries, and related cannabis facilities.

This portfolio provides investors with built-in diversified exposure to the cannabis industry in a single publicly-traded entity. For example, AXIM Biotechnologies (OTCQB: AXIM) and Kannalife provide exposure to the biotech side of the industry while HempMeds and Kannaway are focused on the consumer side.

Reaching a Tipping Point

Medical Marijuana Inc.’s stock has soared more than 140% over the past few weeks, as the market begins to realize the company’s potential. This, coupled with the “November Election Factor,” has led a turnaround in many out-of-favor cannabis stocks over the past weeks.  The prior cycle, MJNA peaked at 48 cents based on future speculation of cannabis law reform.  The advance this period is partly based on speculation – but there are now significant fundamental forces taking hold.

In October, the company announced that Axim Biotech acquired the funding needed to continue its clinical trials across multiple indications. Its MedChew cannabinoid-medicated chewing gum, for example, will soon undergo clinical trials in Europe for pain and spasticity in multiple sclerosis patients. Its Cannabigerol topical cream will similarly undergo European trials evaluating its safety and efficacy and psoriasis and eczema.

Earlier this year, the company successfully expanded its HempMeds distribution into several countries including Mexico, Brazil, Paraguay, and Puerto Rico. In Mexico, Dr. Carlos G. Aguirre Velazquez also conducted a study that evaluated the effectiveness of CBD oil in helping treat refractory epilepsy. The findings showed that 16% of the participants were completely free of seizures with average seizure reduction of 67% with zero adverse side effects.  This compares extremely favorably to US based pharmaceutical development for refractory epilepsy.

The news from these portfolio companies could provide further catalysts for the stock over the coming quarters as the company seeks to enter new markets, launch new products, and secure approvals from health regulators around the world. At the same time, the legalization of cannabis in the United States across several states – and potentially nationwide – could open the door to significantly higher revenue in many areas of the industry.

Looking Ahead

Medical Marijuana Inc. represents a compelling opportunity to profit from the burgeoning cannabis industry, particular with U.S. elections potentially opening the door to new markets. With its highly diversified presence in the space, investors benefit from diversification across multiple areas of the industry with a steady stream of potential catalysts for the stock price.

For more information, visit the company’s website at www.medicalmarijuanainc.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading